Exposure therapy could be a promising treatment for adolescents with eating disorders
Whether you’re fearful of canine, needles or enclosed areas, a single of the most helpful
Disorders
Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy
On-monitor to initiate Phase 2 demo in Q1 2023 NEW YORK, Dec. 29, 2022 /PRNewswire/